Picture of Solgenics logo

SGN Solgenics News Story

0.000.00%
gb flag iconLast trade - 00:00
UtilitiesHighly SpeculativeMicro Cap

REG - Solgenics Limited - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230505:nRSE5785Ya&default-theme=true

RNS Number : 5785Y  Solgenics Limited  05 May 2023

News Release

 

PDMR Dealing

 

5 May 2023: Solgenics Limited (the "Company") announces it has been notified
that on 4 May 2023, Scott Fletcher, Non-Executive Director, purchased an
aggregate of 11,944,347 ordinary shares of no par value in the Company
("Shares").

Scott Fletcher's purchases were made in compliance with the Company's share
dealing policy, increasing his beneficial interest in Ordinary Shares in the
Company to 154,423,436 Ordinary Shares, representing 27.26 per cent. of the
Company's issued share capital.

Enquiries

For further information please visit www.solgenics.com
(http://www.solgenics.com) or contact:

 Solgenics:                 Hanno Pengilly                                 +27 (0) 71 362 3566
 Liberum Capital Limited:   Scott Mathieson, Edward Thomas, Kane Collings  +44 (0) 20 3100 2000

NOMAD & Joint Broker

 Novum Securities Limited   Colin Rowbury                                  +44 (0) 20 7399 9427

 Joint Broker
                            Elizabeth Johnson                              +44 (0) 777 56 55 927

 Pimlico Advisory Ltd

 Investor Relations

 

About Solgenics

Solgenics is an African renewable energy development company focused on the
development of a 300MW solar PV plus BESS renewable energy in the Tete
Province in northern Mozambique (the "Tete Solar Project").

It is the intention that the Tete Solar Project will connect to the Mozambique
grid with target power offtakers in Mozambique and the Southern African Power
Pool ("SAPP").

The Tete Solar Project takes full advantage of Mozambique's leading
sustainable energy resources and is fully aligned with Government's objective
to become a champion for energy transition impacting all Southern Africa.

On 3 May 2023, Solgenics announced that it will shortly be posting a circular
to shareholders (in connection with a proposal for the cancellation of
admission of the ordinary shares of no par value in the Company ("Ordinary
Shares") to trading on AIM (the "Cancellation"), pursuant to Rule 41 of the
AIM Rules for Companies. Accordingly, if the resolution to approve the
cancellation is approved by shareholders, the last day of dealings in the
Ordinary Shares on AIM is expected to be 6 June 2023, and the Cancellation is
expected to become effective at 7.00 a.m. on 7 June 2023.

The notification below is made in accordance with the requirements of the MAR.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 

 

  1   Details of the person discharging managerial responsibilities / person closely
      associated

 a)   Name                                                         Scott Fletcher

 2    Reason for the notification

 a)   Position/status                                              Non-Executive Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Ncondezi Energy Limited

 b)   LEI                                                          2138003W7PP9STE9J18

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of no par value

      Identification code

                                                                   VGG640631039
 b)   Nature of the transaction                                    On-market purchase of Ordinary Shares

 c)   Price(s) and volume(s)

Price(s) GBP      Volume(s)
                                                                   1.   0.002        1.   1,000,000

                                                                   2.   0.002286     2.   5,000,000

                                                                   3.   0.002285     3.   5,000,000

                                                                   4.   0.00224      4.   944,347

 

 d)   Aggregated information

      - Aggregated volume

      - Price                                                      11,944,347

                                                                   0.00226 GBP

 e)   Date of the transaction                                      4 May 2023

 f)   Place of the transaction                                     London Stock Exchange, AIM

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

11,944,347

 

0.00226 GBP

 

 

e)

Date of the transaction

4 May 2023

 

 

f)

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSSUSAIEDSEFI

Recent news on Solgenics

See all news